I. Noguera

发表

Plasminogen/plasminogen activator and growth factor activation.

D. Rifkin, P. Gleizes, R. Mazzieri, 1997, Ciba Foundation symposium.

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

A. F. Stewart, L. Macdonald, A. Murphy, 2003, Nature Biotechnology.

Phosphorylation of HSP25 during lens cell differentiation.

J. Sredy, I. Noguera, R. Chiesa, 1997, Experimental eye research.

TGF-beta latency: biological significance and mechanisms of activation.

D. Rifkin, P. Gleizes, R. Mazzieri, 1997, Stem cells.

Proteolytic control of growth factor availability

D. Rifkin, D B Rifkin, R Mazzieri, 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

A. F. Stewart, L. Macdonald, A. Murphy, 2003, Nature Biotechnology.

Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.

Gavin Thurston, A. Murphy, G. Yancopoulos, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Molecular cloning of the mouse Ltbp-1 gene reveals tissue specific expression of alternatively spliced forms.

D. Rifkin, P. Cowin, A. Gualandris, 2003, Gene.

TGF‐β Latency: Biological Significance and Mechanisms of Activation

D. Rifkin, P. Gleizes, R. Mazzieri, 1997 .

The latent transforming growth factor-beta-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium.

D. Rifkin, A. Gualandris, M. Arese, 2000, Molecular biology of the cell.

Genetic modulation of pigment epithelium–derived factor (PEDF) expression does not alter normal or pathological angiogenesis in the eye, or tumor growth.

G. Yancopoulos, R. Renard, N. Gale, 2004 .